
Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray research solution for detecting genome-wide biomarkers in ovarian and breast cancers.

Explore advanced methods for detecting monoclonal proteins, including mass spectrometry-based analysis. Learn to address challenges in paraproteinemia diagnosis and understand therapeutic antibody interference.

Explore advancements in mass spectrometric analysis of large molecules for clinical applications. Learn key components, recent progress, and resources for efficient protein quantitation in clinical laboratories.

Explore DNA methylation biomarkers in lung cancer through a novel targeted NGS panel, overcoming technical limitations for potential clinical applications in diagnosis and treatment.

Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray solution for cancer research, focusing on PARP inhibitors and synthetic lethality in tumors.

Uncover the potential of loop-mediated isothermal amplification (LAMP) technology, its rapid DNA amplification mechanism, and transformative applications in disease diagnostics and point-of-care testing.

Explore intact light chain quantitation for measuring therapeutic mAb concentrations in human serum using Orbitrap Exploris 240 MS. Learn about simplified workflows and solutions for challenging mAbs.

Explore HIV-1 drug resistance surveillance, focusing on South Africa's efforts and a new genotyping kit targeting protease, reverse-transcriptase, and integrase inhibitors.

Explore real-world application of translating complex genomic data into personalized cancer care, focusing on NGS testing and variant interpretation for hereditary cancers.

Explore a global federated system for biosurveillance using genomic, epidemiological, climate, and environmental data to model biological risks and enhance pandemic early warning capabilities.

Explore AI-driven functional precision medicine for cancer, combining live-cell assays, immune profiling, and machine learning to predict drug efficacy and improve treatment outcomes.

Explore the benefits of combining short read whole genome sequencing, optical genome mapping, and transcriptome analysis for improved constitutional and cancer diagnostics.

Explore a novel long-read sequencing method for detecting single-strand DNA mismatches and damage, enabling new insights into mutation origins in healthy tissues and cancer.

Explore the shift from traditional culture methods to PCR in infectious disease diagnostics, focusing on improved speed, accuracy, and patient care implications.

Explore long-read sequencing's advantages in genome analysis, focusing on accuracy improvements for complex genes and large-scale cohort studies in personalized medicine initiatives.

Explore inflammatory myopathies, their classification, and laboratory detection methods for associated autoantibodies. Gain insights into pathophysiology and current diagnostic approaches.

Explore precision medicine's impact on population health, from genomics in oncology to pharmacogenomics. Learn about broad sequencing panels and their potential to alter disease trajectories across populations.

Explore cutting-edge tools for liquid biopsy in cancer research, enhancing early detection and treatment effectiveness. Learn from expert Dr. Laure Jobert about innovative approaches to combat this global health challenge.

Learn strategies for selecting clinically relevant targets when developing infectious disease molecular panels, and understand the impact on reimbursement. Gain insights from experts on creating effective diagnostic tests.

Explore tissue preparation techniques for multiplex imaging in spatial biology, enhancing molecular detection and spatial resolution for advanced research applications.

Explore how non-B DNA structures affect sequencing errors across Illumina, PacBio HiFi, and Oxford Nanopore technologies, and learn their implications for genomic studies.